Bryce-Smith, Samuel;
(2025)
Characterising the dysregulation of TDP-43 mediated alternative polyadenylation in ALS.
Doctoral thesis (Ph.D), UCL (University College London).
Preview |
Text
Bryce-Smith_10203091_thesis_id_removed.pdf Download (13MB) | Preview |
Abstract
Nuclear loss and cytoplasmic aggregation of TAR DNA-binding protein 43 (TDP-43) occurs in up to 97% of amyotrophic lateral sclerosis (ALS) and 45% of frontotemporal dementia (FTD) patients. TDP-43 point mutations also cause ALS and FTD, indicating a central role of TDP-43 dysfunction in these disorders. TDP-43 nuclear depletion impairs cryptic splicing repression, disrupting key neuronal gene expression. Disease-causative TDP-43 mutations present a splicing gain-of-function, implicating altered RNA processing in ALS-FTD pathogenesis. This thesis analyses RNA-sequencing data from cellular and in vivo models to investigate how TDP-43 dysfunction affects RNA alternative polyadenylation (APA) regulation and its relevance in disease. Firstly, I present results from a community-driven benchmarking study, in which I was a core contributor, to evaluate algorithms for APA detection and quantification using bulk RNA sequencing data. We developed a framework for reproducible, extensible benchmarking, highlighting the poor performance of de-novo inference methods relative to reference-based methods. Using these results, I analysed bulk RNA-sequencing data from TDP-43 mutant mouse models to contrast the effects of loss and gain-of-function mutations on APA regulation within 3’UTRs, uncovering a gain-of-function mimicking that of alternative splicing. Lastly, I developed a computational pipeline to identify novel APA events extending 3’UTRs and occurring within introns. I systematically analysed neuronal TDP-43 depletion bulk RNA-seq datasets to identify cryptic APA events. I integrated post-mortem RNA-seq data from the New York Genome Consortium ALS/FTD dataset to identify events specifically expressed in patients and brain regions affected by TDP-43 proteinopathy, highlighting putative biomarkers and disease contributors. Finally, I integrated orthogonal omics data profiling translation and RNA stability to highlight transcription factors with cryptic 3’UTR extensions that increase RNA stability and translation. Altogether, this thesis expands knowledge of TDP-43 dysfunction impacts on RNA regulation, raising novel disease effectors and markers of TDP-43 proteinopathy for further study
Type: | Thesis (Doctoral) |
---|---|
Qualification: | Ph.D |
Title: | Characterising the dysregulation of TDP-43 mediated alternative polyadenylation in ALS |
Open access status: | An open access version is available from UCL Discovery |
Language: | English |
Additional information: | Copyright © The Author 2025. Original content in this thesis is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) Licence (https://creativecommons.org/licenses/by-nc/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request. |
Keywords: | Neurodegeneration, RNA Biology, Transcriptomics, Bioinformatics |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10203091 |
Archive Staff Only
![]() |
View Item |